Cite
HARVARD Citation
Lin, H. et al. (2018). Effect of FAK inhibitor VS‐6063 (defactinib) on docetaxel efficacy in prostate cancer. Prostate. 78 (4), pp. 308-317. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lin, H. et al. (2018). Effect of FAK inhibitor VS‐6063 (defactinib) on docetaxel efficacy in prostate cancer. Prostate. 78 (4), pp. 308-317. [Online].